Bellerophon Therapeutics, Inc.·4

Jun 25, 4:32 PM ET

Luehring Jens 4

4 · Bellerophon Therapeutics, Inc. · Filed Jun 25, 2018

Insider Transaction Report

Form 4
Period: 2018-06-21
Luehring Jens
Director10% Owner
Transactions
  • Award

    Common Stock

    2018-06-21+14,55595,213 total

Documents

1 file
  • 4
    wf-form4_152995874082020.xmlPrimary

    FORM 4